Predictive Value of Early MRI Measures for Long-Term Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis Receiving IFN β-1a SC tiw or IFN β-1a IM qw: Post Hoc Analyses of the EVIDENCE Study

被引：0
|
作者：
Coyle, Patricia [3 ]
Freedman, Mark [5 ,6 ]
Dangond, Fernando [1 ]
Fang, Juanzhi [2 ]
Reder, Anthony [4 ]
机构：
[1] EMD Serono Inc, Billerica, MA USA
[2] EMD Serono Inc, Rockland, MA USA
[3] SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Univ Ottawa, Ottawa, ON, Canada
[6] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.189
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Long-term safety and tolerability of interferon β-1a in relapsing-remitting multiple sclerosis (RRMS):: Four-year data from the PRISMS study
    Rieckmann, P
    Gold, R
    NEUROLOGY, 2001, 56 (08) : A354 - A354
  • [22] Interferon β-1a SC tiw Reduces Mild to Moderate and Moderate to Severe Relapses and Disease Activity over 1 Year in Patients with Relapsing MS: Post Hoc Analyses of PRISMS Data
    Boster, Aaron
    Li, David
    Williamson, Eric
    Fang, Juanzhi
    Dangond, Fernando
    Traboulsee, Anthony
    NEUROLOGY, 2016, 86
  • [23] No evident disease activity at 24 weeks in patients with relapsing MS treated with interferon β-1a SC vs. interferon β-1a IM in the EVIDENCE study
    Coyle, P. K.
    Fang, J.
    Hassan, A.
    Cha, C.
    Dangond, F.
    Reder, A. T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 113 - 113
  • [24] Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study
    Bastianello, Stefano
    Giugni, Elisabetta
    Amato, Maria Pia
    Tola, Maria-Rosalia
    Trojano, Maria
    Galletti, Stefano
    Luccichenti, Giacomo
    Quarantelli, Mario
    Picconi, Orietta
    Patti, Francesco
    BMC NEUROLOGY, 2011, 11
  • [25] Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study
    Stefano Bastianello
    Elisabetta Giugni
    Maria Pia Amato
    Maria-Rosalia Tola
    Maria Trojano
    Stefano Galletti
    Giacomo Luccichenti
    Mario Quarantelli
    Orietta Picconi
    Francesco Patti
    BMC Neurology, 11
  • [26] Assessing 'no evidence of disease activity' status in patients with relapsing-remitting multiple sclerosis: a long-term follow-up
    Zilli, Chiara
    Rossi, Pietro Scribani
    Di Stadio, Arianna
    Fratino, Mariangela
    Giuliani, Giada
    Annecca, Rosanna
    Russo, Gaetano
    Di Piero, Vittorio
    Altieri, Marta
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [27] Continuous versus non-continuous subcutaneous interferon β-1a treatment in relapsing-remitting multiple sclerosis: long-term data from the PRISMS study
    Uitdehaag, B.
    Kappos, L.
    Verdun, E.
    Gardner, J.
    JOURNAL OF NEUROLOGY, 2009, 256 : S122 - S123
  • [28] TNF-alpha and IGF-1 variation in relapsing-remitting multiple sclerosis patients before and after one year treatment with high dose of IFN beta 1a
    Lus, G.
    Di Biase, G.
    Fratta, M.
    Maniscalco, G.
    Cotrufo, R.
    MULTIPLE SCLEROSIS, 2006, 12 : S192 - S192
  • [29] Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study
    Comi, Giancarlo
    Cook, Stuart
    Rammohan, Kottil
    Sorensen, Per Soelberg
    Vermersch, Patrick
    Adeniji, Abidemi K.
    Dangond, Fernando
    Giovannoni, Gavin
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11 : 1 - 11
  • [30] Subgroup and sensitivity analyses of the primary endpoint from the peginterferon β-1a ADVANCE study: a pivotal phase 3 study in patients with relapsing-remitting multiple sclerosis
    Kieseier, B.
    Calabresi, P.
    Arnold, D.
    Zhu, Y.
    Liu, S.
    Hung, S.
    Deykin, A.
    Sheikh, S.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 222 - 223
12345